HIV-1 Gag specifically restricts PI(4,5)P2 and cholesterol mobility in living cells creating a nanodomain platform for virus assembly.


Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
10 2019
Historique:
received: 31 01 2019
accepted: 09 09 2019
entrez: 17 10 2019
pubmed: 17 10 2019
medline: 22 5 2020
Statut: epublish

Résumé

HIV-1 Gag protein assembles at the plasma membrane of infected cells for viral particle formation. Gag targets lipids, mainly PI(4,5)P2, at the inner leaflet of this membrane. Here, we address the question whether Gag is able to trap specifically PI(4,5)P2 or other lipids during HIV-1 assembly in the host CD4

Identifiants

pubmed: 31616784
doi: 10.1126/sciadv.aaw8651
pii: aaw8651
pmc: PMC6774721
doi:

Substances chimiques

Phosphatidylinositol 4,5-Diphosphate 0
Sphingomyelins 0
gag Gene Products, Human Immunodeficiency Virus 0
Cholesterol 97C5T2UQ7J

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

eaaw8651

Subventions

Organisme : Medical Research Council
ID : MC_UU_00008/9
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12010/9
Pays : United Kingdom
Organisme : NIGMS NIH HHS
ID : R01 GM064347
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom

Informations de copyright

Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).

Références

Methods. 2015 Oct 15;88:67-75
pubmed: 26123184
Nat Commun. 2014 Nov 20;5:5412
pubmed: 25410140
J Lipid Res. 2016 Feb;57(2):299-309
pubmed: 26701325
Methods. 2018 May 1;140-141:62-73
pubmed: 28963070
Virus Res. 2013 Feb;171(2):332-40
pubmed: 22989508
Nat Methods. 2015 Sep;12(9):827-30
pubmed: 26214129
Nat Cell Biol. 2019 Apr;21(4):413-415
pubmed: 30936476
Proc Natl Acad Sci U S A. 2006 Jul 25;103(30):11364-9
pubmed: 16840558
Biochim Biophys Acta Biomembr. 2018 Nov;1860(11):2436-2445
pubmed: 30028957
J Mol Biol. 2015 Mar 27;427(6 Pt B):1480-1494
pubmed: 25644662
J Cell Biol. 2012 Jan 23;196(2):213-21
pubmed: 22249292
J Lipid Res. 2006 Jul;47(7):1597-8
pubmed: 16645198
Virus Res. 2009 Aug;143(2):162-76
pubmed: 19383519
J Virol. 2007 Nov;81(22):12596-607
pubmed: 17728233
J Mol Biol. 2011 Jul 22;410(4):512-24
pubmed: 21762797
Nat Commun. 2017 Sep 15;8(1):545
pubmed: 28916807
Biophys J. 2015 Feb 3;108(3):596-609
pubmed: 25650927
Elife. 2017 Jun 02;6:
pubmed: 28574338
Biophys J. 2017 Nov 7;113(9):2004-2015
pubmed: 29117524
J Virol. 2008 Nov;82(22):11228-38
pubmed: 18799574
J Virol. 2000 Jun;74(11):5142-50
pubmed: 10799589
Virology. 2018 May;518:264-271
pubmed: 29549788
Biophys J. 2011 Oct 5;101(7):1651-60
pubmed: 21961591
Sci Rep. 2016 Dec 23;6:39332
pubmed: 28008947
Virus Res. 2015 Dec 2;210:18-21
pubmed: 26191619
Biochemistry. 2006 Jan 31;45(4):1227-33
pubmed: 16430218
Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2641-6
pubmed: 16481622
Cell Microbiol. 2013 Feb;15(2):292-304
pubmed: 23279151
Virus Res. 2014 Nov 26;193:108-15
pubmed: 24998886
Cell Host Microbe. 2008 May 15;3(5):285-92
pubmed: 18474355
J Virol. 2015 Feb;89(3):1756-67
pubmed: 25410868
Methods Enzymol. 2013;519:1-38
pubmed: 23280106
ACS Nano. 2018 Aug 28;12(8):8540-8546
pubmed: 30028588
Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13925-30
pubmed: 11717449
J Virol. 2004 Oct;78(19):10803-13
pubmed: 15367647
Nat Cell Biol. 2019 Apr;21(4):452-461
pubmed: 30936472
Nature. 2008 Jul 10;454(7201):236-40
pubmed: 18500329
J Virol. 2008 Mar;82(5):2405-17
pubmed: 18094158
Proc Natl Acad Sci U S A. 2004 Oct 12;101(41):14889-94
pubmed: 15465916
Biophys J. 2008 Mar 1;94(5):L32-4
pubmed: 18096628
J Phys Chem Lett. 2018 Sep 20;9(18):5527-5533
pubmed: 30192549
J Virol. 2004 Oct;78(19):10556-65
pubmed: 15367622
J Virol. 2016 Apr 14;90(9):4544-4555
pubmed: 26912608
PLoS Pathog. 2009 Nov;5(11):e1000652
pubmed: 19893629
Cold Spring Harb Perspect Med. 2012 Jul;2(7):a006924
pubmed: 22762019
Phys Chem Chem Phys. 2016 Oct 19;18(41):28409-28417
pubmed: 27757455
Biochim Biophys Acta. 2012 Jul;1818(7):1777-84
pubmed: 22450237
J Mol Biol. 2016 Apr 24;428(8):1637-55
pubmed: 26992353
Cell Microbiol. 2013 Feb;15(2):237-47
pubmed: 23121220
RNA Biol. 2010 Nov-Dec;7(6):744-53
pubmed: 21157181
J Virol. 2000 Apr;74(7):3264-72
pubmed: 10708443
Proc Natl Acad Sci U S A. 2012 Nov 13;109(46):18761-6
pubmed: 23010924
Biophys J. 2004 Apr;86(4):1969-86
pubmed: 15041641
J Virol. 2015 Aug;89(15):7861-73
pubmed: 25995263
PLoS Comput Biol. 2014 Oct 23;10(10):e1003911
pubmed: 25340788
Nat Rev Microbiol. 2015 Aug;13(8):484-96
pubmed: 26119571
Viruses. 2018 Aug 08;10(8):
pubmed: 30096847
J Virol. 1994 Apr;68(4):2556-69
pubmed: 8139035
Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5622-6
pubmed: 19304798
Biophys J. 2014 Feb 4;106(3):577-85
pubmed: 24507598
J Virol. 2011 Dec;85(23):12733-41
pubmed: 21917964
Sci Rep. 2018 Nov 2;8(1):16283
pubmed: 30389967
Nature. 2009 Feb 26;457(7233):1159-62
pubmed: 19098897

Auteurs

C Favard (C)

Montpellier Infectious Disease Research Institute, IRIM, CNRS-Université Montpellier, 1919, route de Mende, 34293 Montpellier Cedex, France.

J Chojnacki (J)

MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK.
IrsiCaixa AIDS Research Institute, University Hospital Germans Trias i Pujol, Ctra. de Canyet s/n, Badalona, 08916 Barcelona, Spain.

P Merida (P)

Montpellier Infectious Disease Research Institute, IRIM, CNRS-Université Montpellier, 1919, route de Mende, 34293 Montpellier Cedex, France.

N Yandrapalli (N)

Montpellier Infectious Disease Research Institute, IRIM, CNRS-Université Montpellier, 1919, route de Mende, 34293 Montpellier Cedex, France.

J Mak (J)

Institute for Glycomics, Griffith University Gold Coast, Southport, QLD, Australia.

C Eggeling (C)

MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK.
Institute of Applied Optics and Biophysics, Friedrich-Schiller-University Jena, Max-Wien Platz 4, 07743 Jena, Germany.
Leibniz Institute of Photonic Technology e.V., Albert-Einstein-Straße 9, 07745 Jena, Germany.

D Muriaux (D)

Montpellier Infectious Disease Research Institute, IRIM, CNRS-Université Montpellier, 1919, route de Mende, 34293 Montpellier Cedex, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH